+499.5%
MRNA vs UVXY
-70.9%
+570.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | UVXY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.7% | -2.9% | -2.0% |
| 7D | +5.5% | -5.0% | +10.5% | +3.6% |
| 30D | +158.7% | -20.5% | +179.3% | +144.4% |
| 3M | +182.1% | -36.6% | +218.7% | +156.7% |
| 6M | +151.8% | -56.9% | +208.7% | +117.5% |
| YTD | +393.6% | -51.2% | +444.8% | +338.2% |
| 1Y | +499.5% | -69.8% | +569.2% | +417.1% |
| All | +499.5% | -70.9% | +570.3% | +417.1% |
Cumulative growth
Daily Returns
Daily percentage return beside UVXY.
Daily Out/Under-Performance
Portfolio return minus UVXY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × UVXY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded UVXY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling